What a day. This morning bought shares at $1.55, then $1.56, and last before market at $1.67.
I believe the last update was in March:請問
UCLA Dr. Liau’s Keytruda/ DCXAx-L trial, 有新消息嗎。很久看不到新的update.
$NWBO: The federally-funded Patient-Centered Outcomes Research Institute (PCORI) selected #DCVax as 1 of the new & emerging health care technologies & innovations with high potential for disruption to the current standard of care (SOC). See Page 36: https://t.co/jfty5wzmDg pic.twitter.com/uU4UtiARqX
— ATLnsider (@ATLnsider) June 22, 2021
New long for me $NWBO. Sounds like the top line phase 3 data will be revealed in next month or so, at worst by end of the year. Worth the risk at this level. Big competitors ready to buy it for 8 figures if data is good. Thanks @thegirltrader_ for the idea. Go follow her!
— Reilly McAdams (@reilly_mcadams) June 23, 2021
You know there's been a quiet period for 8 months since data lock.
You know the content of the March 16th. PR
You know the content of the May 12th. PR
You know what was said during the May 18th ASM
You know whats going on in Sawston with application
— The Danish Dude (@FlemmingBruce) June 20, 2021